The Valley Desk

NCT01499420 · Interventional trial

A Single Ascending Dose Study Examining the Safety and Pharmacokinetic Profile of Reconstituted High Density Lipoprotein (CSL112) Administered to Patients

Overall registry status Completed

Phase 2

Conditions Stable Atherothrombotic Disease

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov